Edge Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$7.72M Sell
303,988
-36,628
-11% -$945K 0.06% 218
2016
Q4
$8.76M Sell
340,616
-4,460
-1% -$117K 0.07% 218
2016
Q3
$9.45M Hold
345,076
0.08% 220
2016
Q2
$9.73M Sell
345,076
-57,420
-14% -$1.48M 0.09% 209
2016
Q1
$9.51M Sell
402,496
-205,060
-34% -$4.52M 0.09% 206
2015
Q4
$13.7M Sell
607,556
-23,988
-4% -$547K 0.13% 187
2015
Q3
$14.6M Sell
631,544
-33,728
-5% -$846K 0.15% 173
2015
Q2
$16.4M Buy
665,272
+165,372
+33% +$4.13M 0.15% 185
2015
Q1
$12.5M Buy
499,900
+33,200
+7% +$789K 0.11% 204
2014
Q4
$10.8M Buy
466,700
+104,456
+29% +$2.39M 0.1% 212
2014
Q3
$8.47M Buy
362,244
+6,000
+2% +$141K 0.08% 227
2014
Q2
$8.24M Hold
356,244
0.08% 232
2014
Q1
$7.6M Buy
356,244
+10,000
+3% +$225K 0.08% 227
2013
Q4
$8.2M Buy
346,244
+100
+0% +$2.17K 0.09% 213
2013
Q3
$6.93M Sell
346,144
-15,200
-4% -$288K 0.08% 212
2013
Q2
$6.24M Buy
+361,344
New +$6M 0.08% 201

Other funds holding TECH

Edge Asset Management's TECH Position: Q1 2017 in Review

Edge Asset Management reduced its Bio-Techne (TECH) stake by 11% in Q1 2017, selling an estimated $945K and leaving 303,988 shares worth $7.72M. The position accounts for 0.06% of the portfolio, ranked #218.

Edge Asset Management first reported a position in TECH in Q2 2013 and has held it in 16 quarters since. The position peaked at $16.4M in Q2 2015. 271 funds tracked by Wall St. Rank hold TECH as of Q1 2017.

  • Edge Asset Management held 303,988 shares of Bio-Techne worth $7.72M as of Q1 2017.
  • Edge Asset Management sold 36,628 Bio-Techne shares in Q1 2017, an estimated $945K.
  • Bio-Techne made up 0.06% of Edge Asset Management's portfolio in Q1 2017, its #218 holding.
  • Edge Asset Management first reported a position in Bio-Techne in Q2 2013 and has held it in 16 quarters since.
  • Edge Asset Management's Bio-Techne position peaked at $16.4M in Q2 2015.
  • 271 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.